PARTIAL LIPODYSTROPHY
Clinical trials for PARTIAL LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new PARTIAL LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for PARTIAL LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test hormone blocker to tame severe insulin resistance
Disease control Recruiting nowThis study is testing if a drug that blocks growth hormone can help people with severe insulin resistance caused by rare fat storage disorders or specific genetic mutations. Twenty-five adults will give themselves daily injections of the drug for one month while researchers measu…
Matched conditions: PARTIAL LIPODYSTROPHY
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Registry launched to track Real-World effects of rare disease drug
Knowledge-focused Recruiting nowThis study is creating a registry to monitor patients who are already taking the drug metreleptin for lipodystrophy, a rare disorder affecting body fat. The goal is to collect long-term safety information on side effects and how well the treatment works in everyday medical practi…
Matched conditions: PARTIAL LIPODYSTROPHY
Sponsor: Amryt Pharma • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC